Divergent synthesis of all possible optically active regioisomers of myo-inositol mono- and bisphosphates

Journal of Carbohydrate Chemistry

Volumn 26, Issue 5-6, 2007, Pages 305-327

  Seo, Kyung Chang ^a   Yu, Seok Ho ^a   Chung, Sung Kee ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

Divergent synthesis; Inositol phosphates; Myo inositol; Phosphorylation; Protecting groups

Indexed keywords

EID: 34548408611     PISSN: 07328303     EISSN: 15322327     Source Type: Journal    
DOI: 10.1080/07328300701540225     Document Type: Article

References (26)

1. Berridge, M.J. Inositol trisphosphate and calcium signalling. Nature 1993, 361, 315-325.
2. (a) Shears, S.B. The versatility of inositol phosphates as cellular signals. Biochim. Biophys. Acta 1998, 1436, 49-67;
3. (b) Irvine, R.F.; Schell, M.J. Back in the water: the return of the inositol phosphates. Nature Rev. Mol. Cell. Biol. 2001, 2, 327-338;
4. (c) Chi, T.H.; Crabtree, G.R. Inositol phosphates in the nucleus. Science 2000, 287, 1937-1939.
5. Odom, A.R.; Stahlberg, A.J.; Wente, S.R.; York, J.D. A role for nuclear inositol-1,4,5-trisphosphate kinase in transcriptional control. Science 2000, 287, 2026-2029.
6. Macbeth, M.R.; Schubert, H.L.; VanDemark, A.P.; Ligam, A.T.; Hill, C.P.; Bass, B.L. Inositol hexakisphosphate is bound in the ADAR2 core and required for RNA editing. Science 2005, 309, 1534-1539.
7. Sylvia, V.; Curtin, G.; Norman, J.; Stec, J.; Busbee, D. Activation of a low specific activity form of DNA polymerase α by inositol-1,4- bisphosphate. Cell 1988, 54, 651-658.
8. Huang, C.; Liang, N.C. Increase in cytoskeletal actin induced by inositol 1,4-bisphosphate in saponin-permeated pig platelets. Cell Biol. Int. 1994, 18, 797-804.
9. Nahorski, S.R.; Ragan, C.I.; Challiss, R.A.J. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharm. Sci. 1991, 12, 297-303.
10. Berridge, M.J.; Downes, C.P.; Hanley, M.R. Neural and developmental actions of lithium: a unifying hypothesis. Cell 1989, 59, 411-419.
11. (a) Yoshikawa, T.; Kikuchi, M.; Saito, K.; Watanabe, A.; Yamada, K.; Shibuya, H.; Nanki, M.; Kurumaji, A.; Hattori, E.; Ishiguro, H.; Shimizu, H.; Okubo, Y.; Toru, M.; Detera-Wadleigh, S.D. Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples. Mol. Psychiatry 2001, 6, 202-210;
12. (b) Sjøholt, G.; Ebstein, R. P.; Lie, R.T.; Berle, J.Ø.; Mallet, J.; Deleuze, J.F.; Levinson, D.F.; Laurent, C.; Mujahed, M.; Bannoura, I.; Murad, I.; Molven, A.; Steen, V.M. Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder. Mol. Psychiatry 2004, 9, 621-629.
13. Potter, B.V.L.; Lampe, D. Chemistry of inositol lipid mediated cellular signaling. Angew. Chem. Int. Edn. Engl. 1995, 34, 1933-1972.
14. (a) Chung, S.K.; Chang, Y.T. Synthesis of all possible regioisomers of myo-inositol tetrakisphosphates. J. Chem. Soc., Chem. Commun. 1995, 11-12;
15. (b) Chung, S.K.; Chang, Y.T.; Sohn, K.H. Practical divergent synthesis of all possible regioisomers of myo-inositol trisphosphates. J. Chem. Soc., Chem. Commun. 1996, 163-164;
16. (c) Chung, S.K.; Chang, Y.T. Synthesis of all possible regioisomers of myo-inositol pentakisphosphates. Bioorg. Med. Chem. Lett. 1996, 6, 2039-2042;
17. (d) Chung, S.K.; Chang, Y.T. A divergent synthesis of all possible regioisomers of myo-inositol monophosphate. Korean J. Med. Chem. 1996, 6, 162-165;
18. (e) Chung, S.K.; Chang, Y.T.; Kwon, Y.U. Syntheses of all regioisomers of myoinositol bisphosphates. J. Carbohydr. Chem. 1998, 369-384.
19. Chung, S.K.; Kwon, Y.U.; Shin, J.H.; Chang, Y.T.; Lee, C.G.; Shin, B.G.; Kim, K.C.; Kim, M.J. Divergent syntheses of all possible optically active regioisomers of myoinositol tris- and tetrakisphosphate. J. Org. Chem. 2002, 67, 5626-5637.
20. Chung, S.K.; Chang, Y.T.; Lee, E.J.; Shin, B.G.; Kwon, Y.U.; Kim, K.C.; Lee, D.H.; Kim, M.J. Syntheses of two enantiomeric pairs of myo-inositol(1,2,4, 5,6) and -(1,2,3,4,5) pentakisphosphate. Bioorg. Med. Chem. Lett. 1998, 8, 1503-1506.
21. Kwon, Y.U.; Lee, C.G.; Chung, S.K. Facile syntheses of all possible diastereomers of conduritol and various derivatives of inositol stereoisomers in high enantiopurity from myo-inositol. J. Org. Chem. 2002, 67, 3327-3338.
22. Desai, T.; Gigg, J.; Gigg, R.; Martín-Zamora, E.; Schnetz, N. The synthesis and resolution of (±)-1,4-di-O-benzyl-2,3-O-isopropylidene-myo- inositol. Carbohydr. Res. 1994, 258, 135-144.
23. Cerè, V.; Mantovani, G.; Peri, F.; Pollicino, S.; Ricci, A. A general procedure to enantiopure conduritols: sulfur-mediated synthesis of (+)-conduritol B and (-)-conduritol F derivatives and of (-)-conduritol E and F. Tetrahedron 2000, 56, 1225-1231.
24. Colobert, F.; Tito, A.; Khiar, N.; Denni, D.; Medina, M.A.; Martin-Lomas, M.; Ruano, J.L.G.; Solladiè, G. Enantioselective approach to polyhydroxylated compounds using chiral sulfoxides: synthesis of enantiomerically pure myo-inositol and pyrrolidine derivatives. J. Org. Chem. 1998, 63, 8918-8921.
25. 3 receptor binding. Bioorg. Med. Chem. Lett. 1998, 8, 659-662.
26. Shashidhar, M.S.; Volwerk, J.J.; Griffith, O.H.; Keana, J.F.W. A chromogenic substrate of phosphatidylinositol-specific phospholipase C: 4-nitrophenyl myo-inositol1-phosphate. Chem. Phys. Lipids 1991, 60, 101-110.